Search for: "WARNER-LAMBERT CO V US"
Results 1 - 20
of 124
Sort by Relevance
|
Sort by Date
2 Apr 2024, 4:50 am
Lord Justice Arnold found that Warner-Lambert continues to apply in the UK and applies to both second medical use and single compounds claims. [read post]
17 Oct 2023, 3:40 pm
The English test was developed by the English Supreme Court in a case that concerned sufficiency rather than inventive step [the Warner-Lambert case – RL[3]]. [read post]
6 Apr 2023, 6:38 am
So moving to plausibility, the present plausibility test set by the UK Supreme Court in Warner-Lambert is whether the patent contains “something that would cause the skilled person to think that there was a reasonable prospect that the assertion would prove to be true”. [read post]
7 Jul 2022, 7:15 am
Continuing, he also noted that in Warner-Lambert Co LLC v Generics (UK) Ltd (t/a Mylan) [2018] UKSC 56, the Supreme Court “upheld the distinction drawn between amendments to delete claims that have been held to be invalid and amendments designed to make good a claim not thus far advanced in the amended form”, in other words confirming that what the Court of Appeal had said in IPCom and Nikken was correct. [read post]
2 Nov 2020, 3:00 pm
Warner-Lambert Co. v. [read post]
13 Mar 2020, 1:53 am
A case in point is Warner-Lambert v Generics (UK).However, applications for second-use patents are increasing, so there must be various other incentives and efficiencies at play. [read post]
9 Feb 2019, 2:13 am
| The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling" | No pain, no gain: Plausibility in Warner-Lambert v Actavis | Testing the boundaries of subjectivity: Infringement of Swiss-type claims in Warner-Lambert v Actavis | Is SPINNING generic? [read post]
6 Feb 2019, 6:12 am
| The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling" | No pain, no gain: Plausibility in Warner-Lambert v Actavis | Testing the boundaries of subjectivity: Infringement of Swiss-type claims in Warner-Lambert v Actavis | Is SPINNING generic? [read post]
2 Jul 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
28 Jun 2017, 9:26 am
Norwich supplies a principled rationale for granting injunctions against non-parties who facilitate wrongdoing (see Cartier, at paras. 51-55; and Warner-Lambert Co. v. [read post]
6 May 2017, 10:11 am
In Warner-Lambert Co v. [read post]
2 Feb 2017, 1:22 pm
Ed. 2d 726 (2016) (concurred in opinion) Court’s determination not unreasonable and counsel not deficient Warner v. [read post]
16 Dec 2016, 4:44 am
.* Wild Boys Sometimes Lose It: Duran Duran fail to reclaim their US copyrightDavid Brophy brings his insightful and readable-as-always analysis of the Duran Duran copyright battle, discussing on how the wild boys lost (for now) and stressing the crucial importance of obtaining good advice when the bargaining position is unequal.* AIPPI Rapid Response Report: Debating Lyrica's recurring pain on plausibility, abuse and infringementIn a guest post, Kat friend Steven Willis… [read post]
7 Dec 2016, 11:58 pm
Just over a year ago, AIPPI hosted a Rapid Response seminar following Mr Justice Arnold finding that the material claims of Warner-Lambert’s patent for the use of pregabalin in the treatment of pain were invalid and in any event not infringed by Actavis’ skinny label pregabalin product Lecaent (Warner-Lambert v Actavis [2015] EWHC 2548 (Pat)). [read post]
18 Nov 2016, 12:44 am
John Collins, Sumer Dayal and Natalie ShoolmanClayton Utz by John Collins, Natalie Shoolman & Sumer Dayal On 21 October 2016, the Federal Court of Australia handed down its judgment in the case of Apotex Pty Ltd v Warner-Lambert Company LLC (No 2) [2016] FCA 1238 (FCA Judgment). [read post]
2 May 2016, 9:50 am
Warner–Lambert Co., 424 F.3d 249, 254 (2d Cir.2005). [read post]
5 Apr 2016, 6:32 am
Ever the optimist, Mark Ridgway seessolutions on the horizon by way ofpurposive construction ofsecond medical use claimsMark Ridgway (Allen & Overy LLP) who co-led the Lyrica litigation in the UK on behalf of Warner-Lambert reminded the audience that whether a medical use patent can be effectively enforced has wider repercussions than just second medical uses, since first medical uses can also be affected. [read post]
11 Jan 2016, 4:22 am
In 2015, readers could see him put his mental martial arts to test in AP Racing v Alcon [2015] EWHC 1371, Warner-Lambert v Actavis on behalf of the Highland Health Board [2015] EWHC 72 and Global Flood Defence System v Van den Noort Innovations [2015] EWHC 153. [read post]
17 Dec 2015, 5:50 pm
Warner–Lambert Co., 799 F.Supp. 1342, 1346 (E.D.N.Y.1992) (quoting Glucksman v. [read post]
13 Dec 2015, 4:01 pm
**********PREVIOUSLY, ON NEVER TOO LATENever too late 75 [week ending on Sunday 6 December] – BHG on blocking injunctions | IP in Universities | Sweden on blocking injunctions | Canadian musings on patents | US Senate and trade secret reform | Chinese IP Courts | G1/14 referral and Article 108 EPC | PACE procedure (Procedure for Accelerated Conduct of Examination) ant the EPO | Greekat and trade mark partenalism | EPO Boards of Appeal tell AC:… [read post]
